{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T03:56:17Z","timestamp":1784174177429,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,7]]},"DOI":"10.7759\/cureus.55755","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T04:44:24Z","timestamp":1709873064000},"source":"Crossref","is-referenced-by-count":2,"title":["Rifampicin Resistance Pattern of Mycobacterium tuberculosis Infection in Tertiary Care Hospital Settings"],"prefix":"10.7759","author":[{"given":"Avantika","family":"Ranganathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durai Singh","family":"Carmelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman","family":"Muthusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.76","article-title":"Tuberculosis","volume":"2","author":"Pai M","year":"2016","unstructured":"Pai M, Behr MA, Dowdy D, et al.. Tuberculosis. Nat Rev Dis Primers. 2016, 2:16076. 10.1038\/nrdp.2016.76","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0002319","article-title":"Assessment of drug-susceptible and multidrug-resistant tuberculosis (MDR-TB) in the Central Region of Somalia: a 3-year retrospective study","volume":"3","author":"Mohamed MA","year":"2023","unstructured":"Mohamed MA, Ali OA, Osman AM, et al.. Assessment of drug-susceptible and multidrug-resistant tuberculosis (MDR-TB) in the Central Region of Somalia: a 3-year retrospective study. PLOS Glob Public Health. 2023, 3:e0002319. 10.1371\/journal.pgph.0002319","journal-title":"PLOS Glob Public Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/507s4a","article-title":"Infectious disease: beating the big three","volume":"507","author":"Bourzac K","year":"2014","unstructured":"Bourzac K. Infectious disease: beating the big three. Nature. 2014, 507:S4-7. 10.1038\/507s4a","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/mmi.14912","article-title":"Antimicrobial resistance","volume":"117","author":"da Silva Dantas A","year":"2022","unstructured":"da Silva Dantas A. Antimicrobial resistance. Mol Microbiol. 2022, 117:959-60. 10.1111\/mmi.14912","journal-title":"Mol Microbiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-021-00488-x","article-title":"Epidemiological profile of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis among Congolese patients","volume":"20","author":"Elion Assiana DO","year":"2021","unstructured":"Elion Assiana DO, Abdul JB, Linguissi LS, et al.. Epidemiological profile of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis among Congolese patients. Ann Clin Microbiol Antimicrob. 2021, 20:84. 10.1186\/s12941-021-00488-x","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.TBTB2-0023-2016","article-title":"Latent Mycobacterium tuberculosis infection and interferon-gamma release assays","volume":"4","author":"Pai M","year":"2016","unstructured":"Pai M, Behr M. Latent Mycobacterium tuberculosis infection and interferon-gamma release assays. Microbiol Spectr. 2016, 4:10.1128\/microbiolspec.TBTB2-0023-2016","journal-title":"Microbiol Spectr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117594","article-title":"Tuberculosis vaccine: a journey from BCG to present","volume":"252","author":"Fatima S","year":"2020","unstructured":"Fatima S, Kumari A, Das G, Dwivedi VP. Tuberculosis vaccine: a journey from BCG to present. Life Sci. 2020, 252:117594. 10.1016\/j.lfs.2020.117594","journal-title":"Life Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.01.068","article-title":"Can what have we learnt about BCG vaccination in the last 20\u00a0years help us to design a better tuberculosis vaccine?","volume":"40","author":"Dockrell HM","year":"2022","unstructured":"Dockrell HM, Butkeviciute E. Can what have we learnt about BCG vaccination in the last 20\u00a0years help us to design a better tuberculosis vaccine?. Vaccine. 2022, 40:1525-33. 10.1016\/j.vaccine.2021.01.068","journal-title":"Vaccine"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0293194","article-title":"Antimicrobial drug resistant features of Mycobacterium tuberculosis associated with treatment failure","volume":"18","author":"Mushtaq F","year":"2023","unstructured":"Mushtaq F, Raza SM, Ahmad A, Aslam H, Adeel A, Saleem S, Ahmad I. Antimicrobial drug resistant features of Mycobacterium tuberculosis associated with treatment failure. PLoS One. 2023, 18:e0293194. 10.1371\/journal.pone.0293194","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-015-0267-y","article-title":"Safety and tolerability profile of second-line anti-tuberculosis medications","volume":"38","author":"Ramachandran G","year":"2015","unstructured":"Ramachandran G, Swaminathan S. Safety and tolerability profile of second-line anti-tuberculosis medications. Drug Saf. 2015, 38:253-69. 10.1007\/s40264-015-0267-y","journal-title":"Drug Saf"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2261","article-title":"The treatment of tuberculosis","volume":"110","author":"Peloquin CA","year":"2021","unstructured":"Peloquin CA, Davies GR. The treatment of tuberculosis. Clin Pharmacol Ther. 2021, 110:1455-66. 10.1002\/cpt.2261","journal-title":"Clin Pharmacol Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2017.01.042","article-title":"Role of second-line injectable antituberculosis drugs in the treatment of MDR\/XDR tuberculosis","volume":"50","author":"Quenard F","year":"2017","unstructured":"Quenard F, Fournier PE, Drancourt M, Brouqui P. Role of second-line injectable antituberculosis drugs in the treatment of MDR\/XDR tuberculosis. Int J Antimicrob Agents. 2017, 50:252-4. 10.1016\/j.ijantimicag.2017.01.042","journal-title":"Int J Antimicrob Agents"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcot.2021.02.006","article-title":"Gene Xpert\/MTB RIF assay for spinal tuberculosis- sensitivity, specificity and clinical utility","volume":"16","author":"Karthek V","year":"2021","unstructured":"Karthek V, Bhilare P, Hadgaonkar S, Kothari A, Shyam A, Sancheti P, Aiyer SN. Gene Xpert\/MTB RIF assay for spinal tuberculosis- sensitivity, specificity and clinical utility. J Clin Orthop Trauma. 2021, 16:233-8. 10.1016\/j.jcot.2021.02.006","journal-title":"J Clin Orthop Trauma"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0000000000003225","article-title":"Diagnostic efficacy, sensitivity, and specificity of Xpert MTB\/RIF assay for spinal tuberculosis and rifampicin resistance","volume":"45","author":"Patel J","year":"2020","unstructured":"Patel J, Upadhyay M, Kundnani V, Merchant Z, Jain S, Kire N. Diagnostic efficacy, sensitivity, and specificity of Xpert MTB\/RIF assay for spinal tuberculosis and rifampicin resistance. Spine (Phila Pa 1976). 2020, 45:163-9. 10.1097\/BRS.0000000000003225","journal-title":"Spine (Phila Pa 1976)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.7.2231-2235.2003","article-title":"Allele-specific rpoB PCR assays for detection of rifampin-resistant Mycobacterium tuberculosis in sputum smears","volume":"47","author":"Mokrousov I","year":"2003","unstructured":"Mokrousov I, Otten T, Vyshnevskiy B, Narvskaya O. Allele-specific rpoB PCR assays for detection of rifampin-resistant Mycobacterium tuberculosis in sputum smears. Antimicrob Agents Chemother. 2003, 47:2231-5. 10.1128\/AAC.47.7.2231-2235.2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s100960050492","article-title":"Comparison of the automated nonradiometric Bactec MGIT 960 system with L\u00f6wenstein-Jensen, Coletsos, and Middlebrook 7H11 solid media for recovery of mycobacteria","volume":"19","author":"Idigoras P","year":"2000","unstructured":"Idigoras P, Beristain X, Iturzaeta A, Vicente D, P\u00e9rez-Trallero E. Comparison of the automated nonradiometric Bactec MGIT 960 system with L\u00f6wenstein-Jensen, Coletsos, and Middlebrook 7H11 solid media for recovery of mycobacteria. Eur J Clin Microbiol Infect Dis. 2000, 19:350-4. 10.1007\/s100960050492","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1198-743X.2004.00825.x","article-title":"Multicentre quality control study for detection of Mycobacterium tuberculosis in clinical samples by nucleic amplification methods","volume":"10","author":"Noordhoek GT","year":"2004","unstructured":"Noordhoek GT, Mulder S, Wallace P, van Loon AM. Multicentre quality control study for detection of Mycobacterium tuberculosis in clinical samples by nucleic amplification methods. Clin Microbiol Infect. 2004, 10:295-301. 10.1111\/j.1198-743X.2004.00825.x","journal-title":"Clin Microbiol Infect"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_1950_16","article-title":"Index-TB guidelines: guidelines on extrapulmonary tuberculosis for India","volume":"145","author":"Sharma SK","year":"2017","unstructured":"Sharma SK, Ryan H, Khaparde S, et al.. Index-TB guidelines: guidelines on extrapulmonary tuberculosis for India. Indian J Med Res. 2017, 145:448-63. 10.4103\/ijmr.IJMR_1950_16","journal-title":"Indian J Med Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020458","article-title":"Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB\/RIF assay--a clinical validation study","volume":"6","author":"Rachow A","year":"2011","unstructured":"Rachow A, Zumla A, Heinrich N, et al.. Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB\/RIF assay--a clinical validation study. PLoS One. 2011, 6:e20458. 10.1371\/journal.pone.0020458","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(10)62173-3","article-title":"Tuberculosis","volume":"378","author":"Lawn SD","year":"2011","unstructured":"Lawn SD, Zumla AI. Tuberculosis. Lancet. 2011, 378:57-72. 10.1016\/s0140-6736(10)62173-3","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.10.2054","article-title":"Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis","volume":"37","author":"Telenti A","year":"1993","unstructured":"Telenti A, Imboden P, Marchesi F, Schmidheini T, Bodmer T. Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis. Antimicrob Agents Chemother. 1993, 37:2054-8. 10.1128\/AAC.37.10.2054","journal-title":"Antimicrob Agents Chemother"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00330-06","article-title":"Mutations prevalent among rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam","volume":"44","author":"Caws M","year":"2006","unstructured":"Caws M, Duy PM, Tho DQ, Lan NT, Hoa DV, Farrar J. Mutations prevalent among rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam. J Clin Microbiol. 2006, 44:2333-7. 10.1128\/JCM.00330-06","journal-title":"J Clin Microbiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.4.1075-1077.2000","article-title":"Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis","volume":"44","author":"Heep M","year":"2000","unstructured":"Heep M, Rieger U, Beck D, Lehn N. Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2000, 44:1075-7. 10.1128\/AAC.44.4.1075-1077.2000","journal-title":"Antimicrob Agents Chemother"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)00286-0","article-title":"Structural mechanism for rifampicin inhibition of bacterial RNA polymerase","volume":"104","author":"Campbell EA","year":"2001","unstructured":"Campbell EA, Korzheva N, Mustaev A, et al.. Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell. 2001, 104:901-12. 10.1016\/S0092-8674(01)00286-0","journal-title":"Cell"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.4103\/lungindia.lungindia_98_17","article-title":"Multidrug-resistant tuberculosis\/rifampicin-resistant tuberculosis: principles of management","volume":"35","author":"Prasad R","year":"2018","unstructured":"Prasad R, Gupta N, Banka A. Multidrug-resistant tuberculosis\/rifampicin-resistant tuberculosis: principles of management. Lung India. 2018, 35:78-81. 10.4103\/lungindia.lungindia_98_17","journal-title":"Lung India"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/228264-rifampicin-resistance-pattern-of-mycobacterium-tuberculosis-infection-in-tertiary-care-hospital-settings","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T04:44:27Z","timestamp":1709873067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/228264-rifampicin-resistance-pattern-of-mycobacterium-tuberculosis-infection-in-tertiary-care-hospital-settings"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.55755","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,7]]}}}